Learn
Understand what epigenetic testing can and cannot offer before deciding.
The Science and For Patients pages explain the concepts behind the assessment in plain language.

Epigenomic research · DNA methylation · Clinical science
Medical Affairs
The Test
VERITAS EPI analyses DNA methylation patterns associated with biological aging and selected health related pathways, and reports them within clinical context.
At a glance
Start here. Each question is answered in the sections below, in the order most people need them.
A DNA methylation based assessment of biological aging signals.
Chronological age records time; it does not describe cellular change.
Consultation, sample, laboratory analysis, modelling, interpretation.
A structured biological aging profile rather than a single number.
It does not diagnose disease, predict lifespan or reverse aging.
01, What is it?
The assessment reads chemical marks on DNA, mainly methylation at CpG sites, that help regulate how genes are used.
Methylation patterns shift with age in ways that research groups have used to build biological age models. VERITAS EPI applies validated models of this kind to laboratory methylation data.
The result is a biological aging profile with several dimensions, each presented with its evidence level and limitations. It is intended for the people who should be interpreting it together: the individual and a qualified healthcare professional.
02, Why does it matter?
Two people of the same age can differ considerably in the biological changes taking place in their cells and tissues.
Chronological age is the time since birth. Biological aging describes what is happening inside the body over that time. Epigenetic information offers one measurable view of that process.
Used responsibly, it can add a layer of biological context to a prevention focused conversation. It does not replace medical history, examination or conventional laboratory testing.
03, How does it work?
Each stage is documented. Specimen type, turnaround and laboratory details are published once confirmed for the final assay.
Understand what epigenetic testing can and cannot offer before deciding.
The Science and For Patients pages explain the concepts behind the assessment in plain language.

The individual and a healthcare professional decide whether testing is appropriate.
Intended use and target population will be published with the validated assay documentation.

A validated biological specimen is collected under documented conditions.
The specimen type (for example blood or saliva) is confirmed with the final assay. Information to be confirmed.

Sample processing, DNA extraction, methylation analysis, quality control, then computational analysis.
Validated algorithms translate methylation data into selected biological aging measures. Samples failing quality control are not reported.

Results are placed alongside clinical history and conventional investigations.
Each measure is accompanied by its reference information, confidence and limitations.

The report highlights areas that may warrant discussion, monitoring or further clinical evaluation.
Whether repeat measurement is appropriate depends on the assay's validated methodology.

Illustrative representation of methylated and unmethylated CpG calls across aligned sequencing reads. Conceptual figure.
Illustrative methylation matrix produced after quality control and normalisation. Conceptual figure, not clinical data.
04, What will I learn?
The report is organised into modules so that every finding sits next to its explanation, its evidence and its limits.
A short overview of the main findings, written in plain clinical language so that patient and physician start from the same understanding.
Domains appear in a report only after they have been validated for the assay.
How assessments differ
A neutral comparison of approaches. Items marked for VERITAS EPI are claimed only once verified for the final assay.
DNA methylation analysis
Biological age model
Medical context
Physician involvement
Clinical documentation
Repeat measurement
Regulatory status
05, What can it not tell me?
Knowing the limits of a measurement is part of understanding it.
The assessment gives no life expectancy or individual longevity forecast.
It is not a diagnostic test and does not replace clinical investigation.
Associations reported in research do not explain an individual result.
No claim is made that biological aging can be reversed or stopped.
Results are meant to be interpreted with a qualified healthcare professional.
Each measure is reported with its confidence and reference limitations.
Laboratory methylation analysis under a documented quality system.
Validated computational models with declared references.
Findings read alongside clinical history and conventional tests.
Plain language explanations, references and limitations.
Common questions
The specimen type will be confirmed with the validated assay and published in the sample requirements. Information to be confirmed.
Turnaround times will be published with the ordering workflow once laboratory operations are finalised.
The assessment is designed to be interpreted with a healthcare professional. Ordering requirements depend on the regulatory framework in each jurisdiction.
Repeat measurement is only meaningful when the methodology has been validated for it. This will be stated explicitly once confirmed.
Consent, storage and retention are described on the Quality, Regulatory and Privacy page.